Elicio Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Elicio Therapeutics, Inc. (ELTX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -1.40% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-17.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2023-03-17
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -1.40%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was -2.80%, a 354.55% decline from fiscal 2020.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2020 was 1.10%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2022-12-31 | -1.40% 10-K · filed 2023-03-17 |
| 2021-12-31 | -2.80% 10-K · filed 2023-03-17 |
| 2020-12-31 | 1.10% 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |